TSRO Related Analyst Ratings
-
Leerink Swann Jacks Tesaro (TSRO) Price Target 47% Higher
-
Deutsche Boosts PT on Tesaro (TSRO) to $80; Likes Netupitant, Potential for Niraparib
-
Leerink Swann Boosts PT on Tesaro (TSRO)
-
Deutsche Bank Starts Tesaro (TSRO) at Buy; Best in Class Drug
-
Management, Pipeline Make Tesaro (TSRO) an Attractive Speculative Play - Cramer
-
BMO Capital Starts Tesaro (TSRO) at Outperform
-
UPDATE: Baird Starts Tesaro (TSRO) at Outperform; Proven Management Team and Business Model
-
Leerink Swann Starts Tesaro (TSRO) at Outperform; Successful Track Record; Potential Understated
-
Morgan Stanley Starts Tesaro (TSRO) at Overweight
-
Citi Starts Tesaro (TSRO) at Buy
Back to TSRO Stock Lookup
